hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06389929 id: IU-HB-RK-02 briefTitle: Do the Health Education Materials Developed in the Gynecology and Diseases Nursing Course Affect Students' Teaching Material Motivation and Material Design Self-Efficacy Beliefs? overallStatus: COMPLETED date: 2023-10-30 date: 2024-01-20 date: 2024-01-28 date: 2024-04-29 date: 2024-04-29 name: Inonu University class: OTHER briefSummary: Purpose: This study aimed to examine the effect of health education material developed by nursing students in gynecological health and disease nursing on students' teaching material motivation and material design self-efficacy belief.
Method: The study was conducted as a prospective randomized controlled study. n=86 (43=control, 43=intervention) students who took the Women's Health and Diseases Nursing course at Bartın University Faculty of Health Sciences Nursing Department between 30.10.2023-20.01.2024 and volunteered to participate in the study were randomized. It was conducted in two groups: intervention and control.In the research, data will be collected with the Data Collection Form prepared by reviewing the literature, Instructional Material Motivation Scale and Material Design Self-Efficacy Belief Scale. Descriptive statistics, Student t-test, Mann-Whitney U Test, Wilcoxon Signed Rank Test and Pearson correlation tests will be used to evaluate the data. conditions: Nursing Caries studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Prospective randomized controlled n = 86 (43 = control, 43 = intervention) students who took the Women's Health and Diseases Nursing course at Bartın University, Faculty of Health Sciences, Department of Nursing and volunteered to participate in the study were randomly assigned to two groups: intervention and control. primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 92 type: ACTUAL name: Education measure: Instructional Material Motivation Scale measure: Material Design Self-Efficacy Belief Scale sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Simge OZTURK city: Bartin state: None Selected zip: 74100 country: Turkey lat: 41.63583 lon: 32.3375 hasResults: False
nctId: NCT06389916 id: EU-PHX-RCT-001 briefTitle: Euclid Phoenix Lens Design Trial overallStatus: ACTIVE_NOT_RECRUITING date: 2023-11-01 date: 2024-04 date: 2024-04 date: 2024-04-29 date: 2024-04-29 name: Euclid Systems Corporation class: INDUSTRY briefSummary: The "first fit" success rate of the current Euclid orthokeratology "MAX" lens design will be compared to that of the new Euclid orthokeratology MAX "Phoenix" lens design in 30 children. conditions: Myopia conditions: Cornea studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: Euclid orthokeratology MAX (current design) name: Euclid orthokeratology MAX Phoenix (new design) measure: First fit success rate sex: ALL minimumAge: 6 Years maximumAge: 18 Years stdAges: CHILD stdAges: ADULT facility: Insight Vision Center Optometry city: Costa Mesa state: California zip: 92626 country: United States lat: 33.64113 lon: -117.91867 facility: Dau Family Eye Care city: Saint Johns state: Florida zip: 32259 country: United States lat: 30.0815 lon: -81.54774 facility: Cornea and Contact Lens Institute of Minnesota city: Edina state: Minnesota zip: 55436 country: United States lat: 44.88969 lon: -93.34995 facility: Somerset Eye Care city: North Brunswick state: New Jersey zip: 08902 country: United States lat: 40.454 lon: -74.482 facility: Treehouse Eyes city: Tysons Corner state: Virginia zip: 22182 country: United States lat: 38.91872 lon: -77.23109 hasResults: False
nctId: NCT06389903 id: 2018-A00185-50 briefTitle: Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease acronym: PSYLES-STIM overallStatus: COMPLETED date: 2019-06-04 date: 2020-07-03 date: 2021-10-05 date: 2024-04-29 date: 2024-04-29 name: Centre Hospitalier du Rouvray class: OTHER_GOV briefSummary: This is a pilot, prospective, monocentric study concerning 15 Parkinson's disease patients requiring deep brain stimulation implantation.
The primary objective is to evaluate the psychiatric lesion effects of deep brain stimulation in patients with Parkinson's disease, using the Young Mania Rating Scale (YMRS), Big Five Inventory and the Hamilton Depression Rating Scale (HAMD 21). conditions: Parkinson Disease studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 15 type: ACTUAL name: assessment measure: Assessment of change of mania symptoms measure: Assessment of change of depressive symptoms measure: Assessment of change of Behavior measure: Assessment of change of Impulsivity measure: Assessment of change of Apathy measure: Assessment of personality measure: Assessment of executive functions measure: Assessment of confusion sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Marie Desbordes, MD city: Sotteville Les Rouen zip: 76300 country: France lat: 49.40972 lon: 1.09005 hasResults: False
nctId: NCT06389890 id: PaSuTE briefTitle: Pancreatic Surgery - Optimal Caseload Thresholds and Predictive Accuracy acronym: PaSuT overallStatus: COMPLETED date: 2010-01-01 date: 2019-12-31 date: 2019-12-31 date: 2024-04-29 date: 2024-04-29 name: Richard Hunger class: OTHER name: Medizinische Hochschule Brandenburg Theodor Fontane briefSummary: The main objective of the study is to identify the optimal annual number of cases in a hospital with regard to minimising hospital mortality in pancreatic surgery. In particular, the prognostic value of such case numbers will be analysed. conditions: Volume-Outcome Relationship in Pancreatic Surgery studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 80000 type: ACTUAL name: Pancreatic resection procedure measure: In-hospital mortality sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06389877 id: BTX-302-001 briefTitle: A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2027-06 date: 2027-08 date: 2024-04-29 date: 2024-04-29 name: Beam Therapeutics Inc. class: INDUSTRY briefSummary: This is a Phase 1/2, multicenter, open-label, dose-exploration (Phase 1) and dose-expansion (Phase 2) study to evaluate the safety, tolerability, PK/PD, and efficacy of BEAM-302 in adult patients with AATD-associated lung disease and/or liver disease and to determine the optimal biological dose (OBD). conditions: Alpha 1-Antitrypsin Deficiency studyType: INTERVENTIONAL phases: PHASE1 phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 106 type: ESTIMATED name: BEAM-302 measure: Phase 1 Dose Exploration: Rates of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs) measure: Phase 2 Dose Expansion: Absolute blood levels of total AAT measure: Phase 1 Dose Exploration: Absolute blood levels of total AAT measure: Phase 2 Dose Expansion: Rates of TEAEs and SAEs sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Clinical Study Center city: London country: United Kingdom lat: 51.50853 lon: -0.12574 hasResults: False
nctId: NCT06389864 id: rTMS in ADHD briefTitle: rTMS in Children and Adolescents With ADHD: overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2026-04 date: 2026-10 date: 2024-04-29 date: 2024-04-29 name: Assiut University class: OTHER briefSummary: Assess the effect of RTMS on ADHD symptoms and assessment of this effect clinically and objectively. conditions: ADHD studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 60 type: ESTIMATED name: rTMS (repetitive transcranial magnetic stimulation) measure: The resting motor threshold (RMT) measure: Arabic version Conners' Parent Rating Scale - Revised Long form measure: Clinical Global Impression CGI sex: ALL minimumAge: 6 Years maximumAge: 18 Years stdAges: CHILD stdAges: ADULT hasResults: False
nctId: NCT06389851 id: NAFLD-LYCOPENE briefTitle: Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD overallStatus: NOT_YET_RECRUITING date: 2024-05-20 date: 2025-05-20 date: 2025-05-20 date: 2024-04-29 date: 2024-04-29 name: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis class: OTHER name: Dr. Di Stasi Vincenza name: Dr. Donvito Rosanna name: Dr. Cozzolongo Raffaele name: Dr. Giannuzzi Vito name: Dr. Zappimbulso Marianna name: Dr. Shahini Endrit name: Dr. Notarnicola Maria name: Dr. Russo Francesco name: Dr. Riezzo Giuseppe name: Dr. Donghia Rossella name: Dr. Cesternino Anna Maria name: Dr. Cici Rosalisa name: Dr. Cerabino Nicole name: Dr. Martina Di Chito name: Dr. Pesole Pasqua Letizia name: Dr. Coletta Sergio name: Dr. Stabile Dolores name: Dr. Ancona Anna name: Dr. D'Attoma Benedetta name: Dr. Ignazzi Antonia name: Dr. De Nunzio Valentina name: Dr. Tatoli Rossella name: Dr. Pinto Giuliano briefSummary: The study in question is an interventional study with nutritional intervention. the aim of the study is to evaluate whether a diet enriched with tomatoes can have favorable effects on:
* symptoms of IBS (irritable bowel syndrome) in patients with NAFLD. conditions: NAFLD conditions: IBS studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The study evaluates the effects on NAFLD, Intestinal Integrity and Microbiota of a diet enriched with tomatoes compared to a diet without tomatoes primaryPurpose: TREATMENT masking: NONE count: 60 type: ESTIMATED name: Experimental: Case Group - Tomato-free diet name: Experimental: Case group - Diet enriched with tomatoes measure: The effect of intervention on CAP value (Controlled Attenuation Parameter) measure: The effect of intervention on FLI value (fatty liver index) measure: The effect of intervention on routine blood chemistry parameters, relating to NAFLD and fibrosis measure: The effect of the intervention on the integrity of the intestinal barrier measure: The effect of the intervention on the microbiota sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Irccs Saverio de Bellis city: Castellana Grotte state: Bari zip: 70013 country: Italy lat: 40.88643 lon: 17.16549 hasResults: False
nctId: NCT06389838 id: DINKS01 id: DRKS00033704 type: REGISTRY domain: DRKS id: 2024-512094-27 type: EUDRACT_NUMBER briefTitle: RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application acronym: DINKS overallStatus: NOT_YET_RECRUITING date: 2024-04-29 date: 2024-09-30 date: 2024-12-01 date: 2024-04-29 date: 2024-04-29 name: Kranus Health GmbH class: INDUSTRY name: Johannes Gutenberg University Mainz briefSummary: This study, titled "Prospective Randomized Study on Multimodal Self-Treatment for Women with Incontinence Symptoms Using a Digital Health Application," abbreviated as DINKS, aims to investigate the efficacy of a digital health application in treating incontinence in women. The study involves a single-center, single blinded, randomized, controlled trial with two arms: one receiving digital therapy intervention and the other serving as a control group with standard of care. The primary objective is to reduce the frequency of incontinence episodes over a 12-week intervention period, with secondary goals including improvements in disease symptoms, quality of life, and patient activation. The study plans to recruit 198 female participants and assess various endpoints related to incontinence severity, quality of life, and treatment outcomes. conditions: Urinary Incontinence,Stress conditions: Urinary Incontinence, Urge conditions: Urinary Incontinence conditions: Overactive Bladder Syndrome conditions: Female Urinary Stress Incontinence studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Prospective, randomized, controlled, single-blinded, 2-arm design primaryPurpose: TREATMENT masking: SINGLE maskingDescription: Participants know which group they are assigned to, but the investigators are blinded. whoMasked: INVESTIGATOR count: 198 type: ESTIMATED name: Kranus Mictera measure: Incontinence episodes measure: ICIQ-SF measure: I-QoL measure: PAM-13 measure: PGI-I measure: Cured patients measure: Urinary frequency day measure: Urinary frequency night measure: Pad use measure: Urge incontinence measure: Functional bladder capacity measure: Body weight measure: Treatment Failure sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Kranus Health Gmbh city: München zip: 80331 country: Germany name: Laura E Wiemer, MD role: CONTACT phone: +4989 124 146 79 email: lwiemer@kranushelath.com lat: 48.13743 lon: 11.57549 hasResults: False
nctId: NCT06389825 id: FH-Diet-RX briefTitle: Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia. overallStatus: RECRUITING date: 2024-04-01 date: 2024-06-30 date: 2024-06-30 date: 2024-04-29 date: 2024-04-29 name: Laval University class: OTHER briefSummary: The investigators will conduct a fully controlled dietary randomized crossover trial (RCT) including 10 adults with HeFH using lipid-lowering medication to investigate the impact of a diet low in red and processed meats and high in plant foods, reflecting Canada's Food Guide, in place of a standard North-American diet on LDL-cholesterol (LDL-C) levels and the plasma metabolome. conditions: Familial Hypercholesterolemia conditions: Nutrition, Healthy conditions: Cholesterol, Elevated studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 10 type: ESTIMATED name: Healthy diet measure: Post-diet differences in LDL-C levels. measure: Post-diet differences in plasma metabolomics profiles sex: ALL minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: INAF-NUTRISS Université Laval status: RECRUITING city: Québec zip: G1V0a6 country: Canada name: Valérie Guay role: CONTACT phone: 418-656-2131 email: valerie.guay@fsaa.ulaval.ca lat: 46.81228 lon: -71.21454 hasResults: False
nctId: NCT06389812 id: LoughboroughUni briefTitle: Dual-task Exercise in People With Cognitive Impairment overallStatus: ACTIVE_NOT_RECRUITING date: 2023-08-30 date: 2024-04-30 date: 2024-09-30 date: 2024-04-29 date: 2024-04-29 name: Loughborough University class: OTHER briefSummary: The purpose of this study is to explore how performing two exercise-based tasks simultaneously (dual-task exercise) affects the neurovascular and cognitive responses of people with cognitive impairment, which is a growing concern globally. Specifically, the study will examine how motor-cognitive dual-task exercises, such as using elastic resistance bands combined with visual perception training, including eye movement exercises, can immediately improve outcomes such as Brain-derived neurotrophic factor (BDNF) levels, cerebral blood flow, cognitive function, and mobility. BDNF is a special chemical in our brain that helps with the connections between brain cells. Participants will be asked to complete a single 30-minute exercise session and undergo assessments before and after the intervention. Participants with cognitive impairment will be initially assessed using Mini-Mental State Examination (MMSE) which is a 30-point questionnaire used extensively in clinical and research settings to measure cognitive impairment. Any score of 24 or more (out of 30) indicates normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points), or mild (19-23 points) cognitive impairment. Participants with lower MMSE scores (\<10) will be removed from the study. conditions: Dementia conditions: Mild Cognitive Impairment conditions: Older Adults studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: Dual-task exercise traning measure: BDNF serum level measure: Visual screening sex: ALL minimumAge: 65 Years stdAges: OLDER_ADULT facility: Loughborough University city: Loughborough state: Leicestershire zip: LE11 3TU country: United Kingdom lat: 52.76667 lon: -1.2 hasResults: False
nctId: NCT06389799 id: PERELI id: 2022-501993-21-00 type: CTIS briefTitle: A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) acronym: PERELI overallStatus: NOT_YET_RECRUITING date: 2024-05-07 date: 2027-12-31 date: 2028-12-31 date: 2024-04-29 date: 2024-04-29 name: Lund University Hospital class: OTHER briefSummary: Dedifferentiated liposarcomas (DDLPS) are aggressive soft tissue sarcomas with no effective medical treatment options.
Immunotherapy with checkpoint inhibitors, so-called PD-1 inhibitors, have shown some effect in DDLPS in previous studies. Effect of immunotherapy can be improved by combining it with other types of tumor drugs. Medicines that inhibit signaling via the FGF receptor, so-called FGFR inhibitors, have shown a tumor-slowing effect in DDLPS in early studies. FGFR inhibitors can also induce changes that make the tumor more available to treatment with immunotherapy.
The study aims to investigate whether the combination of an FGFR inhibitor, pemigatinib, with a PD-1 inhibitor, retifanlimab can provide a tumor-slowing effect in patients with advanced DDLPS who have progressed on first-line treatment. conditions: Dedifferentiated Liposarcoma studyType: INTERVENTIONAL phases: PHASE2 allocation: NON_RANDOMIZED interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 33 type: ESTIMATED name: Pemigatinib name: Retifanlimab measure: To evaluate clinical benefit of retifanlimab and pemigatinib in patients with advanced DDLPS measure: To further evaluate clinical efficacy of retifanlimab and pemigatinib in DDLPS measure: To evaluate the safety and tolerability of pemigatinib and retifanlimab measure: To evaluate impact of treatment and disease status on quality of life measure: To evaluate the relationship between baseline and on-treatment biomarkers and clinical activity sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Oslo University Hospital HF city: Oslo country: Norway name: Kjetil Boye, MD role: CONTACT phone: 4722934000 email: kjetil.boye@rr-research.no lat: 59.91273 lon: 10.74609 facility: Sahlgrenska University Hospital city: Göteborg country: Sweden name: Lina Hansson, MD role: CONTACT phone: 46313427950 email: lina.hansson@vgregion.se lat: 57.70716 lon: 11.96679 facility: Lund University Hospital city: Lund country: Sweden name: Helena Nyström, MD role: CONTACT role: CONTACT phone: +4646177520 email: helena.nystrom@skane.se lat: 55.70584 lon: 13.19321 hasResults: False
nctId: NCT06389773 id: 302958 briefTitle: Teamwork for Resilient Staff and Safe Care in ICU acronym: FEARLESS_ICU overallStatus: NOT_YET_RECRUITING date: 2024-09-02 date: 2025-09-30 date: 2025-09-30 date: 2024-04-29 date: 2024-04-29 name: King's College London class: OTHER briefSummary: The goal of this ethnographic study is to observe how healthcare professionals work together in an intensive care unit (ICU). The main questions it aims to answer are
Researchers will shadow staff during their day-to-day work. Key staff members will also be interviewed about their perceptions and experiences of teamwork. conditions: Teamwork studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: OTHER count: 75 type: ESTIMATED measure: Examine the changing nature of teamwork in ICUs in the post-pandemic context sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06389760 id: IST-Nim-PC-16 briefTitle: Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer overallStatus: RECRUITING date: 2023-10-18 date: 2026-09-30 date: 2026-09-30 date: 2024-04-29 date: 2024-04-29 name: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School class: OTHER briefSummary: This is a prospective, multicenter, single-arm, phase II trial. The main purpose of the study is to evaluate the efficacy and safety of Nimotuzumab combined with mFOLFIRINOX for postoperative adjuvant treatment of pancreatic cancer. conditions: Pancreatic Cancer studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 50 type: ESTIMATED name: Nimotuzumab name: mFOLFIRINOX measure: disease-free survival (DFS) measure: distant metastasis-free survival (DMFS) measure: overall survival (OS) measure: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30) measure: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire pancreatic cancer 29 (EORTC-QLQ-PAN26) measure: tumor-related markers measure: adverse events sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School status: RECRUITING city: Nanjing state: Jiangsu zip: 210008 country: China name: Juan Du, M.D. Ph.D role: CONTACT phone: +86-025-83106666 email: dujunglyy@163.com name: Juan Du, M.D. Ph.D role: PRINCIPAL_INVESTIGATOR lat: 32.06167 lon: 118.77778 hasResults: False
nctId: NCT06389747 id: OU briefTitle: Effect of Blood Flow Restriction Technique on Delayed Onset Muscle Soreness overallStatus: RECRUITING date: 2024-04-24 date: 2024-05-28 date: 2024-06-15 date: 2024-04-29 date: 2024-04-29 name: Istanbul University - Cerrahpasa (IUC) class: OTHER briefSummary: The aim of our study is to determine and evaluate the effects of blood flow restriction technique on pain, biomechanical properties and strength of the muscle in delayed onset muscle pain in healthy individuals. A Double Blind, Randomized Controlled, prospective study was planned. conditions: Pain Intensity studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: participants and assessors will be blind to different intensity BFR groups. whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 15 type: ESTIMATED name: BFR technique measure: Visual analog scale measure: myoton measure: dynamometer measure: dolorimeter sex: ALL minimumAge: 18 Years maximumAge: 35 Years stdAges: ADULT facility: Gamze Aydın status: RECRUITING city: Istanbul zip: 34940 country: Turkey name: Gamze Aydın role: CONTACT email: gmzetsn@gmail.com lat: 41.01384 lon: 28.94966 facility: Istanbul Okan University status: RECRUITING city: Istanbul zip: 34944 country: Turkey name: Gamze Aydın, PhD role: CONTACT phone: +905377600256 email: gmzetsn@gmail.com lat: 41.01384 lon: 28.94966 hasResults: False